key articles
Dutasteride: a review of its use in the management of prostate disorders
Thursday, 8 May 2008 - In a 23-page review published in Drugs, Keam and Scott (2008) addressed the management of prostate disorders by dutasteride.
Dutasteride (AvodartŪ), an oral synthetic 4-azasteroid, is a potent, selective,...
Authors: Keam & Scott
Alfuzosin 10 mg once daily for benign prostatic hyperplasia
Wednesday, 7 May 2008 - Vallancien et al. (2008) assessed the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign...
Authors: Vallancien et al.
Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction
Saturday, 5 April 2008 - Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are a common problem in ageing men and are accompanied by sexual dysfunction (SD) in 40-70% of men evaluated in...
Authors: Seftel et al.
Management of restenosis after urethral stent placement
Wednesday, 27 February 2008 - Urethral stenting was first used to treat benign prostatic hyperplasia and later also for urethral strictures and detrusor-sphincter dyssynergia. Longer followup revealed several complications of...
Authors: Eisenberg et al.
Drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction
Thursday, 21 February 2008 - The relationship between erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) caused by benign prostatic obstruction (BPO) has recently gained increasing attention. Both BPO and ED are...
Authors: Gur et
Benign prostatic hyperplasia. Part 1 - diagnosis
Thursday, 21 February 2008 - Lower urinary tract symptoms (LUTS) are often considered to be due to benign prostatic hyperplasia (BPH) or benign prostatic enlargement. However, such symptoms are also common in women and in men...
Authors: Wilt & N'Dow
Transurethral Vapour Resection of Prostate Is a Good Alternative for Prostates >70 g
Sunday, 17 February 2008 - The morbidity associated with transurethral resection of the prostate (TURP) for large-volume prostates has prompted attempts to modify the standard equipment and techniques. Patients with large...
Authors: Gupta et al.
Incontinence related to management of benign prostatic hypertrophy
Tuesday, 5 February 2008 - Male incontinence is a distressing condition affecting a patient's quality of life. Patients with incontinence are characterized with social withdrawal, isolation, and depression and tend to manage...
Authors: Han et al.
Lycopene inhibits disease progression in patients with benign prostate hyperplasia
Tuesday, 29 January 2008 - Lycopene is a promising nutritional component for chemoprevention of prostate cancer (PCa). A possibly beneficial role of lycopene in patients diagnosed with benign prostate hyperplasia (BPH), who are...
Authors: Schwarz et al.
